[Results of trimethoprim and sulfamethoxazole therapy in chronic urinary tract infections].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D013280:Stomatitis / Q000139:chemically induced; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Resultat av trimetoprim sulfametoxazolbehandling vid kroniska urinvägsinfektioner.